Policy & Regulation
FDA accepts Genentech's giredestrant application for early-stage breast cancer
2 June 2026 - Biotechnology company Genentech, a member of the Roche Group (SIX: RO, ROG) (OTCQX: RHHBY), said on Tuesday that the US Food and Drug Administration (FDA) has accepted its New Drug Appli...
Ansun Biopharma reports positive recommendation from independent DMC for DAS181
2 June 2026 - Clinical-stage biopharmaceutical company Ansun Biopharma Inc announced on Monday that its independent Data Monitoring Committee (DMC) has issued a positive recommendation following a pre...
Amgen receives EU marketing authorisation for IMDYLLTRA in ES-SCLC
2 June 2026 - US biopharmaceutical company Amgen (NASDAQ:AMGN) announced on Monday that it has received marketing authorisation from the European Commission for IMDYLLTRA (tarlatamab) as a monotherapy...
Haisco receives US FDA approval for anaesthetic Cipepofol
...
hVIVO secures Decoy Therapeutics consultancy contract for antiviral development
1 June 2026 - Clinical development partner hVIVO plc (AIM: HVO) announced on Monday that it has signed a consultancy agreement with Decoy Therapeutics to support the development of its respiratory ant...
AstraZeneca reports trial results showing immunotherapy combinations reduce progression risk in liver cancer
1 June 2026 - Biopharmaceutical company AstraZeneca plc (STO:AZN) (LON:AZN) (NYSE:AZN) on Monday reported positive results from the EMERALD-3 Phase III trial evaluating IMFINZI (durvalumab) in combina...